Stage IV Gastric Cancer HER2-positive for Peritoneal Foci but Negative for Primary Disease Treated by Curative Operation Following Combination Chemotherapy with Trastuzumab-Reference-Cited by-同舟云学术

Stage IV Gastric Cancer HER2-positive for Peritoneal Foci but Negative for Primary Disease Treated by Curative Operation Following Combination Chemotherapy with Trastuzumab

Published:2016 Issue:9 Volume:49 Page:867-872
ISSN:0386-9768
Container-title:The Japanese Journal of Gastroenterological Surgery
language:en
Short-container-title:Jpn J Gastroenterol Surg, Nihon Shokaki Geka Gakkai zasshi

Author:

Maezawa Yukio¹²,Sato Tsutomu¹²,Kano Kazuki¹²,Segami Kenki¹²,Nakajima Tetsushi¹,Aoyama Toru¹²,Rino Yasushi²,Ogata Takashi¹,Cho Haruhiko¹²,Yoshikawa Takaki¹²

Affiliation:

1. Department of Gastrointestinal Surgery, Kanagawa Cancer Center

2. Department of Surgery, Yokohama City University

Publisher

The Japanese Journal of Gastroenterological Surgery

Subject

Gastroenterology,Surgery

Link

https://www.jstage.jst.go.jp/article/jjgs/49/9/49_2015.0195/_pdf

Reference10 articles.

1. 1) Asmis TR, Capanu M, Kelsen DP, Shah MA. Systemic chemotherapy does not increase the risk of gastrointestinal perforation. Ann Oncol. 2007;18(12):2006–2008.

2. 2) Kang MH, Kim SN, Kim NK, Park YI, Kim YW, Ryu KW, et al. Clinical outcomes and prognostic factors of metastatic gastric carcinoma patients who experience gastrointestinal perforation during palliative chemotherapy. Ann Surg Oncol. 2010;17(12):3163–3172.

3. 3) Roviello F, Rossi S, Marrelli D, De Manzoni G, Pedrazzani C, Morgagni P, et al. Perforated gastric carcinoma: a report of 10 cases and review of the literature. World J Surg Oncol. 2006;4:19.

4. 4) Yang HK, Tsujinaka T, Nakamura K, Kim YW, Terashima M, Han SU, et al. Randomized controlled trial of comparing gastrectomy (Gx) plus chemotherapy (CTX) with CTX alone in advanced gastric cancer (AGC) with a single non-curable factor: JCOG 0705/KGCA01 study (REGATTA). 2015 ASCO Annual Meeting. J Clin Oncol. 2015;33(suppl):abstr 200.

5. 5) Hata T, Sakata N, Kudoh K, Shibata C, Unno M. The best surgical approach for perforated gastric cancer: one-stage vs. two-stage gastrectomy. Gastric Cancer. 2014;17(3):578–587.